Bloomberg -- Sanofi-Aventis SA achieved “stunning” results in an ongoing human trial for its novel cancer drug aimed at breast and lung tumors, Chief Executive Officer Chris Viehbacher said.
Bloomberg -- Sanofi-Aventis SA achieved “stunning” results in an ongoing human trial for its novel cancer drug aimed at breast and lung tumors, Chief Executive Officer Chris Viehbacher said.
